Pettee Investors, Inc. Bristol Myers Squibb CO Transaction History

Pettee Investors, Inc.

$200 Million
Q3 2024

A detailed history of Pettee Investors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pettee Investors, Inc. holds 42,123 shares of BMY stock, worth $2.37 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares

42,123

Previous 42,123 -0.0%

Holding current value

$2.37 Million

Previous $1.75 Million 24.59%

% of portfolio

1.09%

Previous 0.88%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$40.25 - $52.99 $1.06 Million - $1.4 Million	-26,352 Reduced 38.48%	42,123 $1.75 Million
Q1 2024 May 09, 2024	SELL	$47.98 - $54.4 $165,291 - $187,408	-3,445 Reduced 4.79%	68,475 $3.71 Million
Q4 2023 Feb 07, 2024	SELL	$48.48 - $57.85 $23,076 - $27,536	-476 Reduced 0.66%	71,920 $3.69 Million
Q3 2023 Oct 20, 2023	SELL	$57.89 - $64.73 $198,852 - $222,347	-3,435 Reduced 4.53%	72,396 $4.2 Million
Q2 2023 Aug 08, 2023	BUY	$63.71 - $70.74 $63,710 - $70,740	1,000 Added 1.34%	75,831 $4.85 Million
Q1 2023 May 05, 2023	BUY	$65.71 - $74.53 $22,998 - $26,085	350 Added 0.47%	74,831 $5.19 Million
Q4 2022 Jan 25, 2023	BUY	$68.48 - $81.09 $9,587 - $11,352	140 Added 0.19%	74,481 $5.36 Million
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $133 - $78,761	-1,025 Reduced 1.36%	74,341 $5.29 Million
Q2 2022 Jul 25, 2022	SELL	$72.62 - $79.98 $12,345 - $13,596	-170 Reduced 0.23%	75,366 $5.8 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $3,381 - $4,054	55 Added 0.07%	75,536 $5.52 Million
Q4 2021 Feb 11, 2022	BUY	$53.63 - $62.52 $85,486 - $99,656	1,594 Added 2.16%	75,481 $4.71 Million
Q3 2021 Nov 02, 2021	SELL	$59.17 - $69.31 $7,100 - $8,317	-120 Reduced 0.16%	73,887 $4.37 Million
Q2 2021 Aug 02, 2021	BUY	$61.91 - $67.42 $55,719 - $60,678	900 Added 1.23%	74,007 $4.95 Million
Q1 2021 May 03, 2021	BUY	$59.34 - $66.74 $164,668 - $185,203	2,775 Added 3.95%	73,107 $4.62 Million
Q4 2020 Feb 08, 2021	BUY	$57.74 - $65.43 $145,504 - $164,883	2,520 Added 3.72%	70,332 $4.36 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $166,259 - $184,237	2,895 Added 4.46%	67,812 $4.09 Million
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $46,400 - $67,430	1,000 Added 1.56%	64,917 $3.62 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $410,460 - $535,408	8,341 Added 15.01%	63,917 $4.1 Million
Q3 2019 Oct 30, 2019	SELL	$42.77 - $50.71 $12,189 - $14,452	-285 Reduced 0.51%	55,576 $2.82 Million
Q2 2019 Aug 07, 2019	SELL	$44.62 - $49.34 $30,609 - $33,847	-686 Reduced 1.21%	55,861 $2.53 Million
Q4 2018 Feb 06, 2019	SELL	$48.76 - $63.23 $53,636 - $69,553	-1,100 Reduced 1.91%	56,547 $2.94 Million
Q2 2018 Aug 15, 2018	SELL	$50.53 - $62.98 $55,583 - $69,278	-1,100 Reduced 1.87%	57,647 $3.19 Million
Q4 2017 Feb 06, 2018	SELL	$59.94 - $65.35 $5,994 - $6,534	-100 Reduced 0.17%	58,747 $3.6 Million
Q3 2017 Nov 02, 2017	BUY	$55.23 - $63.74 $3.25 Million - $3.75 Million	58,847	58,847 $3.75 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pettee Investors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pettee Investors, Inc. with notifications on news.

Account

Pettee Investors, Inc. Bristol Myers Squibb CO Transaction History